Ghaffari Arshia, Kalantar-Zadeh Kamyar, Lee Joseph, Maddux Franklin, Moran John, Nissenson Allen
Division of Nephrology, Keck School of Medicine, University of Southern California, Los Angeles, California.
Semin Dial. 2013 Nov-Dec;26(6):706-13. doi: 10.1111/sdi.12125. Epub 2013 Sep 19.
Peritoneal dialysis (PD) and in-center hemodialysis (HD) are accepted as clinically equivalent dialysis modalities, yet in-center HD is the predominant renal replacement therapy (RRT) modality offered to new end-stage renal disease (ESRD) patients in the United States and most other industrialized nations. This predominance has little to do with clinical outcomes, patient choice, cost, or quality of life. It has been driven by ease of HD initiation, physician experience and training, inadequate pre-ESRD patient education, ample in-center HD capacity, and lack of adequate infrastructure for PD-related care. As compared with in-center HD, PD is a widely applicable, yet underutilized modality of RRT that provides comparable clinical outcomes, superior quality of life measures, significant cost savings, and many other unmeasured advantages. A "PD First" approach not only has advantages for patients but also physicians, healthcare systems, and society. In this review, we will summarize evidence demonstrating that PD should be the default modality when new ESRD patients are transitioning to dialysis therapy when preemptive transplantation is not an option and highlight the essential infrastructural requirements to allow for a "PD First" model.
腹膜透析(PD)和中心血液透析(HD)在临床上被视为等效的透析方式,但在美国和大多数其他工业化国家,中心血液透析是为新的终末期肾病(ESRD)患者提供的主要肾脏替代治疗(RRT)方式。这种主导地位与临床结果、患者选择、成本或生活质量关系不大。它是由HD启动的便利性、医生的经验和培训、ESRD前患者教育不足、中心HD能力充足以及缺乏与PD相关护理的适当基础设施所驱动的。与中心HD相比,PD是一种广泛适用但未得到充分利用的RRT方式,它能提供相当的临床结果、更好的生活质量指标、显著的成本节约以及许多其他未衡量的优势。“优先选择PD”的方法不仅对患者有利,对医生、医疗系统和社会也有好处。在这篇综述中,我们将总结证据,证明当新的ESRD患者在无法进行抢先移植时过渡到透析治疗时,PD应作为默认方式,并强调实现“优先选择PD”模式所需的基本基础设施要求。